These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 26068641

  • 21. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 22. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
    Collaud S, Lardinois D, Tischler V, Steinert HC, Stahel R, Weder W.
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
    [Abstract] [Full Text] [Related]

  • 23. PET-CT evaluation of 2-deoxy-2-[18F]fluoro-D-glucose myocardial uptake: effect of respiratory motion.
    Chin BB, Nakamoto Y, Kraitchman DL, Marshall L, Wahl R.
    Mol Imaging Biol; 2003 Mar; 5(2):57-64. PubMed ID: 14499145
    [Abstract] [Full Text] [Related]

  • 24. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
    Iagaru A, Quon A, McDougall IR, Gambhir SS.
    Mol Imaging Biol; 2006 Mar; 8(4):212-7. PubMed ID: 16724293
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
    Tsatalpas P, Beuthien-Baumann B, Kropp J, Manseck A, Tiepolt C, Hakenberg OW, Burchert W, Franke WG, Wirth MP.
    Urol Int; 2002 Mar; 68(3):157-63. PubMed ID: 11919460
    [Abstract] [Full Text] [Related]

  • 26. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
    Adams HJ, Nievelstein RA, Kwee TC.
    J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022
    [Abstract] [Full Text] [Related]

  • 27. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

  • 28. 18F-FDG PET/CT imaging in oncology.
    Almuhaideb A, Papathanasiou N, Bomanji J.
    Ann Saudi Med; 2011 Mar; 31(1):3-13. PubMed ID: 21245592
    [Abstract] [Full Text] [Related]

  • 29. 18 F-FDG-PET/CT as adjunctive diagnostic modalities in canine fever of unknown origin.
    Grobman M, Cohn L, Knapp S, Bryan JN, Reinero C.
    Vet Radiol Ultrasound; 2018 Jan; 59(1):107-115. PubMed ID: 28925085
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    Borgatti A, Winter AL, Stuebner K, Scott R, Ober CP, Anderson KL, Feeney DA, Vallera DA, Koopmeiners JS, Modiano JF, Froelich J.
    PLoS One; 2017 Jan; 12(2):e0172651. PubMed ID: 28222142
    [Abstract] [Full Text] [Related]

  • 31. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H.
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [Abstract] [Full Text] [Related]

  • 32. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 33. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 34. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
    Eschmann SM, Bitzer M, Paulsen F, Friedel G, Besenfelder H, Horger M, Reimold M, Dittmann H, Pfannenberg AC, Bares R.
    Nucl Med Commun; 2004 Sep; 25(9):909-15. PubMed ID: 15319596
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [Abstract] [Full Text] [Related]

  • 36. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 37. Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients.
    Flechsig P, Frank P, Kratochwil C, Antoch G, Rath D, Moltz J, Rieser M, Warth A, Kauczor HU, Schwartz LH, Haberkorn U, Giesel FL.
    Mol Imaging Biol; 2017 Apr; 19(2):315-322. PubMed ID: 27539308
    [Abstract] [Full Text] [Related]

  • 38. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Bockisch A, Debatin JF, Freudenberg LS.
    J Clin Oncol; 2004 Nov 01; 22(21):4357-68. PubMed ID: 15514377
    [Abstract] [Full Text] [Related]

  • 39. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL.
    Cancer Res; 2003 Oct 01; 63(19):6252-7. PubMed ID: 14559811
    [Abstract] [Full Text] [Related]

  • 40. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF, Tran T, Holmstrom A, Murar J, Segurola RJ.
    Chest; 2004 Apr 01; 125(4):1413-23. PubMed ID: 15078754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.